EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The Complexity of erm ‐Mediated Resistance: Structural and Functional Perspectives From β‐Hemolytic Streptococci

Lillie M Powell, Rita Berisio, P Rocco LaSala, Slawomir Lukomski iD

Molecular Microbiology · 2026-07 · 126 (1) · 47-59

DOI: 10.1111/mmi.70078 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Microbiology, online erschienen am 15.05.2026. Verfasst von Lillie M Powell und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology, and Cell Biology, West Virginia University School of Medicine, Morgantown, West Virginia, USA. Hauptthemen laut MEDLINE: Methyltransferases, Drug Resistance, Bacterial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macrolide overuse and resulting resistance crippled the applicability of one of the most important and successful classes of antibiotics. The rising incidence of invasive infections caused by β‐hemolytic group A and group B streptococci have been paralleled with marked increases in erythromycin and clindamycin resistance. As a result, resistant invasive group A and group B Streptococcus infections have been classified by the CDC as a concerning level threat since 2019. Acquisition of erythromycin resistance methylase ( erm ) genes is a major contributor of the MLS B [macrolide (i.e., erythromycin), lincosamide (i.e., clindamycin), and streptogramin B] resistance phenotype in US isolates. The erm ‐encoded enzymes utilize the methyl‐group from S‐adenosyl‐L‐methionine (SAM) to methylate the adenosine A2058 residue of bacterial ribosomal RNA, which serves as the overlapping rRNA target site for the three MLS B classes of antibiotics. The major mechanism that regulates Erm methyltransferase production is translational attenuation in the 5′ regulatory region upstream of the erm coding sequence. The 5′ regulatory region of erm includes at least one short leader peptide erm L, with the leader peptide ribosome binding site (SD1), non‐translational stem‐loop structures, and the erm start codon with its ribosome binding site (SD2). Binding of a macrolide antibiotic to the ribosome causes stalling during translation of the erm L peptide, which disrupts and alters the formation of inhibitory mRNA hairpins in the erm 5′ regulatory region, thereby releasing the erm SD2‐site from the posterior stem‐loop hairpin, thus allowing Erm protein translation. The streptococcal ErmA, ErmB, and ErmT proteins have conserved structures with primary sequence conservation of residues involved in SAM‐ and rRNA‐binding activity, as well as a high‐level of structural conservation. However, the observed variation in the erm 5′ regulatory region sequences, transcript expression, and ribosome methylation levels associated with these genes and proteins underscore the regulatory complexity of Erm expression. This review aims to present insights into mechanisms of Erm‐mediated resistance, trends in streptococcal epidemiology and treatment, and progress in the development of improved MLS B drugs that effectively block erm ‐mediated resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethyltransferasesDrug Resistance, BacterialAnti-Bacterial AgentsBacterial ProteinsMacrolidesErythromycinHumansStreptococcal InfectionsStreptococcus pyogenesRNA, RibosomalLincosamides

Stichwörter der Autor:innen

ermMLSBantimicrobial resistanceinvasive group A Streptococcusmethylation

Substanzen

Anti-Bacterial AgentsMethyltransferasesBacterial ProteinsMacrolidesErythromycinRNA, RibosomalLincosamides

Autor:innen und Institutionen

  • Department of Microbiology, Immunology, and Cell Biology, West Virginia University School of Medicine, Morgantown, West Virginia, USA.
  • Institute of Biostructure and Bioimaging, National Research Council, CNR, Naples, Italy.
  • Department of Pathology and Laboratory Medicine, University of Connecticut Health, Farmington, Connecticut, USA.
  • West Virginia Clinical and Translational Institute, West Virginia University School of Medicine, Morgantown, West Virginia, USA.

ORCID-Profile: Slawomir Lukomski

Zitieren

APA

Powell, L. M., Berisio, R., LaSala, P. R., & Lukomski, S. (2026). The Complexity of erm ‐Mediated Resistance: Structural and Functional Perspectives From β‐Hemolytic Streptococci. Molecular Microbiology, 126(1), 47-59. https://doi.org/10.1111/mmi.70078

Vancouver

Powell LM, Berisio R, LaSala PR, Lukomski S. The Complexity of erm ‐Mediated Resistance: Structural and Functional Perspectives From β‐Hemolytic Streptococci. Molecular Microbiology. 2026;126(1):47-59. doi:10.1111/mmi.70078

BibTeX
@article{Powell2026,
  author = {Powell, Lillie M and Berisio, Rita and LaSala, P Rocco and Lukomski, Slawomir},
  title = {The Complexity of erm ‐Mediated Resistance: Structural and Functional Perspectives From β‐Hemolytic Streptococci},
  journal = {Molecular Microbiology},
  year = {2026},
  volume = {126},
  number = {1},
  pages = {47--59},
  doi = {10.1111/mmi.70078}
}
Kostenlos starten →